Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
As an independent company, Tanabe Pharma will continue to build on its legacy of medical innovation while developing new opportunities for growth through business development, licensing activities, enhanced R&D productivity, commercialization and strategic acquisitions.
Mitsubishi Tanabe Pharma Corporation | 10/02/2025 | By Aishwarya
Ethypharm Signs Deal with MTPC to Acquire Argatroban Monohydrate
Ethypharm has signed an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to acquire the selective antithrombin agent, Argatroban monohydrate (Argatra, Arganova, Novastan, Exembol), in Europe.
Mitsubishi Tanabe Pharma Corporation | 18/06/2024 | By Aishwarya | 388
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy